ReviewHepatology international2022

Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5.

Chen-Hua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.